These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15193592)

  • 1. The thalamus as the generator and modulator of EEG alpha rhythm: a combined PET/EEG study with lorazepam challenge in humans.
    Schreckenberger M; Lange-Asschenfeldt C; Lochmann M; Mann K; Siessmeier T; Buchholz HG; Bartenstein P; Gründer G
    Neuroimage; 2004 Jun; 22(2):637-44. PubMed ID: 15193592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression of thalamic metabolism by lorazepam is associated with sleepiness.
    Volkow ND; Wang GJ; Hitzemann R; Fowler JS; Pappas N; Lowrimore P; Burr G; Pascani K; Overall J; Wolf AP
    Neuropsychopharmacology; 1995 Apr; 12(2):123-32. PubMed ID: 7779240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eeg alpha rhythm and glucose metabolic rate in the thalamus in schizophrenia.
    Danos P; Guich S; Abel L; Buchsbaum MS
    Neuropsychobiology; 2001; 43(4):265-72. PubMed ID: 11340367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducibility of regional brain metabolic responses to lorazepam.
    Wang GJ; Volkow ND; Overall J; Hitzemann RJ; Pappas N; Pascani K; Fowler JS
    J Nucl Med; 1996 Oct; 37(10):1609-13. PubMed ID: 8862292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased cerebral response to inhibitory neurotransmission in alcoholics.
    Volkow ND; Wang GJ; Hitzemann R; Fowler JS; Wolf AP; Pappas N; Biegon A; Dewey SL
    Am J Psychiatry; 1993 Mar; 150(3):417-22. PubMed ID: 8382010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring reproducibility of regional brain metabolic responses to lorazepam using statistical parametric maps.
    Wang GJ; Volkow ND; Levy AV; Felder CA; Fowler JS; Pappas NR; Hitzemann RJ; Wong CT
    J Nucl Med; 1999 May; 40(5):715-20. PubMed ID: 10319741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effect of 3-(4-acetamido)-butyrril-lorazepam (DDS2700) on brain function assessed by PET at rest and during attentive tasks.
    Moresco RM; Tettamanti M; Gobbo C; Del Sole A; Ravasi L; Messa C; Paulesu E; Lucignani G; Perani D; Fazio F
    Nucl Med Commun; 2001 Apr; 22(4):399-404. PubMed ID: 11338050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anterior limbic alpha-like activity: a low resolution electromagnetic tomography study with lorazepam challenge.
    Connemann BJ; Mann K; Lange-Asschenfeldt C; Ruchsow M; Schreckenberger M; Bartenstein P; Gründer G
    Clin Neurophysiol; 2005 Apr; 116(4):886-94. PubMed ID: 15792898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects: a PET study.
    Volkow ND; Wang GJ; Fowler JS; Hitzemann R; Gatley SJ; Dewey SS; Pappas N
    Am J Psychiatry; 1998 Feb; 155(2):200-6. PubMed ID: 9464198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional brain metabolism during alcohol intoxication.
    Wang GJ; Volkow ND; Franceschi D; Fowler JS; Thanos PK; Scherbaum N; Pappas N; Wong CT; Hitzemann RJ; Felder CA
    Alcohol Clin Exp Res; 2000 Jun; 24(6):822-9. PubMed ID: 10888070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of gender difference in regional brain metabolic responses to lorazepam.
    Wang GJ; Volkow ND; Fowler JS; Hitzemann RJ; Pappas NR; Netusil N
    Psychiatry Res; 1998 Apr; 82(1):37-46. PubMed ID: 9645549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relations between PET-derived measures of thalamic glucose metabolism and EEG alpha power.
    Larson CL; Davidson RJ; Abercrombie HC; Ward RT; Schaefer SM; Jackson DC; Holden JE; Perlman SB
    Psychophysiology; 1998 Mar; 35(2):162-9. PubMed ID: 9529942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalamic metabolic rate predicts EEG alpha power in healthy control subjects but not in depressed patients.
    Lindgren KA; Larson CL; Schaefer SM; Abercrombie HC; Ward RT; Oakes TR; Holden JE; Perlman SB; Benca RM; Davidson RJ
    Biol Psychiatry; 1999 Apr; 45(8):943-52. PubMed ID: 10386175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of PET and qEEG in normal subjects.
    Alper KR; John ER; Brodie J; Günther W; Daruwala R; Prichep LS
    Psychiatry Res; 2006 Apr; 146(3):271-82. PubMed ID: 16603341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced thalamic and cerebellar rest metabolism in relapsing-remitting multiple sclerosis, a positron emission tomography study: correlations to lesion load.
    Derache N; Marié RM; Constans JM; Defer GL
    J Neurol Sci; 2006 Jun; 245(1-2):103-9. PubMed ID: 16647086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How the cortico-thalamic feedback affects the EEG power spectrum over frontal and occipital regions during propofol-induced sedation.
    Hashemi M; Hutt A; Sleigh J
    J Comput Neurosci; 2015 Oct; 39(2):155-79. PubMed ID: 26256583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.
    Holcomb HH; Cascella NG; Thaker GK; Medoff DR; Dannals RF; Tamminga CA
    Am J Psychiatry; 1996 Jan; 153(1):41-9. PubMed ID: 8540590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interplay of lorazepam-induced brain oscillations: microstructural electromagnetic study.
    Fingelkurts AA; Fingelkurts AA; Kivisaari R; Pekkonen E; Ilmoniemi RJ; Kähkönen S
    Clin Neurophysiol; 2004 Mar; 115(3):674-90. PubMed ID: 15036064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cerebral glucose metabolism between multiple system atrophy Parkinsonian type and Parkinson's disease.
    Feng T; Wang Y; Ouyang Q; Duan Z; Li W; Lu L; Xiang W
    Neurol Res; 2008 May; 30(4):377-82. PubMed ID: 18544255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.